Patient-reported quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: Interim results of the TALLISUR study.

Meinolf Karthaus,Albrecht Kretzschmar,Stefan Fuxius,Jorge Riera-Knorrenschild,Florian Kaiser,Rolf Mahlberg,Manfred Welslau,Henning Pelz,Volker Heinemann

Patient-reported quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: Interim results of the TALLISUR study.

2021

Meinolf Karthaus
Albrecht Kretzschmar
Stefan Fuxius
Jorge Riera-Knorrenschild
Florian Kaiser
Rolf Mahlberg
Manfred Welslau
Henning Pelz
Volker Heinemann

3526Background: Compared to placebo, trifluridine/tipiracil (FTD/TPI) significantly improved overall and progression-free survival in patients (pts) with pre-treated metastatic colorectal cancer (m...

Keywords:

Interim
in patient
Oncology
Medicine
Internal medicine
Colorectal cancer
Trifluridine
Placebo
Tipiracil
Quality of life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations